Validity of the Steep Ramp Test to assess exercise capacity in patients with cancer undergoing chemotherapy
- Conditions
- 10027655cancer and exercise tolerance during chemotherapy treatment
- Registration Number
- NL-OMON40203
- Lead Sponsor
- ederlands Kanker Instituut
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Patients with cancer who will undergo chemotherapy and who have decided to participate in a physiotherapeutic intervention during their chemotherapy treatment.
Approval of treating physician to participate in this study.
Patients with comorbid conditions which would contraindicate participation to a VO2max test.
1. Serious orthopedic conditions
2. Serious cardiovascular or cardiopulmonary conditions (or risks)
Patients with a high risk profile for cardiovascular events according to the ACSM guidelines
3. Patients suffering from malnutrition as evidenced by a BMI < 18 kg/m2, unintended weight loss of more than 5% per month, or more than 10% unintended weight loss during the previous 6 month
4. Serious psychiatric or cognitive problems
5. Lack of basic fluency in the Dutch language.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcomes will be the level of agreement between peak VO2 (VO2peak)<br /><br>and peak power (Wpeak) as assessed with a CPET and the peak power (Wpeak) as<br /><br>assessed with the SRT.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary study outcomes will include fatigue and health-related quality of<br /><br>life (HRQOL). </p><br>